Wow, $10 OPT might feel like a dream—and it sort of is—but hey, it’s not woo-woo! Success in both P3 readouts, FDA approval, and OPT getting re-priced based on expected sales and Big Pharma’s price-to-earnings ratios could make it a reality. Running my numbers, I just can’t wrap my head around what happens after hitting FU money on the share market, which, for me, is anything over OPT at $2. The compounding power of the options just pushes my portfolio into the stratosphere for every dollar over $2!
Anyway, time to gird my loins—this could all come undone, and I could end up with nothing but a warm Fanta and burnt sausage! Will still have my ZIP lambo.
"Risk comes from not knowing what you're doing. Which includes you FFS" — Warren Buffett,
- Forums
- ASX - By Stock
- OPT
- Ann: Security Class Reinstatement to Quotation- OPTOB
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Ann: Security Class Reinstatement to Quotation- OPTOB, page-314
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online